Prospective Views for Whey Protein and/or Resistance Training Against Age-related Sarcopenia
- PMID: 30705776
- PMCID: PMC6345331
- DOI: 10.14336/AD.2018.0325
Prospective Views for Whey Protein and/or Resistance Training Against Age-related Sarcopenia
Abstract
Skeletal muscle aging is characterized by decline in skeletal muscle mass and function along with growing age, which consequently leads to age-related sarcopenia, if without any preventive timely treatment. Moreover, age-related sarcopenia in elder people would contribute to falls and fractures, disability, poor quality of life, increased use of hospital services and even mortality. Whey protein (WP) and/or resistance training (RT) has shown promise in preventing and treating age-related sarcopenia. It seems that sex hormones could be potential contributors for gender differences in skeletal muscle and age-related sarcopenia. In addition, skeletal muscle and the development of sarcopenia are influenced by gut microbiota, which in turn is affected by WP or RT. Gut microbiota may be a key factor for WP and/or RT against age-related sarcopenia. Therefore, focusing on sex hormones and gut microbiota may do great help for preventing, treating and better understanding age-related sarcopenia.
Keywords: age-related sarcopenia; gender differences; gut microbiota; resistance training; sex hormones; whey protein.
Conflict of interest statement
Declarations of interest No conflicts of interest
Figures
References
-
- Fearnley JM, Lees AJ (1991). Ageing and Parkinson’s disease: substantia nigra regional selectivity. Brain, 114(Pt 5):2283-2301. - PubMed
-
- Thompson DD (2007). Aging and sarcopenia. J Musculoskelet Neuronal Interact, 7:344. - PubMed
-
- Nakanishi R, Oki E, Sasaki S, Hirose K, Jogo T, Edahiro K, et al. (2017). Sarcopenia is an independent predictor of complications after colorectal cancer surgery. Surg Today: 1-7. - PubMed
-
- Wendrich AW, Swartz JE, Bril SI, Wegner I, de Graeff A, Smid EJ, et al. (2017). Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer. Oral Oncol, 71:26-33. - PubMed
Publication types
LinkOut - more resources
Full Text Sources